TrialBritish journal of clinical pharmacology2017

Population pharmacokinetics and exposure-response of trastuzumab emtansine in advanced breast cancer previously treated with ≥2 HER2-targeted regimens.

Shang-Chiung Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.